Table 4.

Non-culture-based methods for the diagnosis of IFIs in the patients of the Greek paediatric haematology-oncology units: host hospital’s capacity and total number of tests performed during the years 2019 and 2020.

Diagnostic Tests	Number of Host Hospitals’ Laboratories that Perform the Test	Number of Tests Performed during the Two Years Per Unit
Aspergillus galactomannan	2/8	20–100
1,3-β-D-glucan	1/8	5–80
mannan	0/8	0–100
Anti-mannan	0/8	0–20
Antibodies against Aspergillus	1/8	0–20
Cryptococcus antigen (agglutination)	2/8	0–20
Cryptococcus antigen (lateral flow)	2/8	0–10
IFA for Pneumocystis jirovecii	1/8	0–5
PCR for:
Aspergillus	2/8	6–100
Candida	2/8	10–100
Cryptococcus	2/8	0
Pneumocystis jirovecii	0/8	2–5

IFA: Immunofluorescence Assay.